Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
330 Leser
Artikel bewerten:
(2)

UniqueDentist: Dr. Amir Bajoghli and Skin & Laser Dermatology Center Introduce Sculptra Aesthetic for Advanced Facial Rejuvenation

Finanznachrichten News

Dr. Amir Bajoghli and the Skin & Laser Dermatology Center are excited to announce the addition of Sculptra Aesthetic to their comprehensive range of facial rejuvenation services.

MCLEAN, VA / ACCESSWIRE / August 16, 2024 / Dr. Amir Bajoghli and the Skin & Laser Dermatology Center are excited to announce the addition of Sculptra Aesthetic to their comprehensive range of facial rejuvenation services. This advanced injectable treatment offers a gradual and natural-looking approach to restoring facial volume and reducing signs of aging. As we age, our faces naturally lose volume, leading to the appearance of wrinkles, folds, and a sunken appearance. Dr. Bajoghli and his team are committed to providing cutting-edge solutions that address these concerns effectively and subtly.

Sculptra Aesthetic is a unique dermal filler that works by stimulating the body's natural collagen production. Unlike traditional hyaluronic acid fillers, Sculptra is made from poly-L-lactic acid, a biocompatible synthetic material that gradually restores facial volume over time. This innovative treatment is particularly effective for addressing deep facial wrinkles, nasolabial folds, and hollow areas of the face.

According to statistics from sculptrausa.com, the effectiveness of Sculptra is impressive:

  • 94% of Sculptra patients showed aesthetic improvement for up to 2 years.

  • 95% of Sculptra patients had improved skin glow 2 years after Sculptra treatment.

  • 88% of Sculptra patients had improved skin tightness 2 years after treatment.

  • 89% of Sculptra patients observed improved skin firmness 2 years after treatment.

"We are thrilled to offer Sculptra Aesthetic to our patients, providing them with a long-lasting and natural-looking solution for facial rejuvenation," said Dr. Amir Bajoghli, the founder of Skin & Laser Dermatology Center. "The impressive statistics from sculptrausa.com underscore the effectiveness of this treatment in delivering real, lasting results for our patients."

The Sculptra treatment typically involves a series of injections over a few months, with results developing gradually and lasting up to two years or more. This gradual approach allows for a more natural-looking enhancement, avoiding the sudden changes that can sometimes occur with other injectable treatments.

Sculptra Aesthetic is ideal for patients seeking a subtle yet effective approach to facial rejuvenation. The treatment is suitable for various areas of the face, including the cheeks, temples, and chin, and can be customized to meet each patient's unique needs and aesthetic goals.

Patients can expect usually minimal downtime following Sculptra treatments, with some possible swelling or bruising that typically resolves within a few days. Dr. Bajoghli and his team provide comprehensive pre- and post-treatment care instructions to ensure optimal results and patient comfort.

About Skin & Laser Dermatology Center

Skin & Laser Dermatology Center is a premier medical and cosmetic dermatology practice with locations in McLean and Woodbridge, Virginia. Led by Dr. Amir Bajoghli, the center offers a comprehensive range of services, including treatments for skin conditions such as acne, eczema, and rosacea, as well as cosmetic procedures for brown spots, wrinkles, and facial rejuvenation. The practice is dedicated to providing the highest standard of care, utilizing the latest technologies and techniques in the field of dermatology.

Dr. Amir Bajoghli can be reached at either of his Virginia offices:

McLean:
1359 Beverly Rd., 2nd Floor
McLean, VA 22101
(703) 893-1114

Woodbridge:
2200 Opitz Blvd., Suite 100
Woodbridge, VA 22191
(703) 492-4140

Contact Information

Jill K
PR
hi@featureddoctor.com

Related Video

https://www.youtube.com/watch?v=XVkYgUjKMtc

SOURCE: Skin & Laser Dermatology Center



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.